To correct genetic defects in GCD patient cells, we designed a disease-specific guide RNA (gRNA) targeting the R124H mutation of TGFBI, which causes GCD type 2 (GCD2). This evidence concerns the gene TGFBI and granular corneal dystrophy type II.